New omicron sublineages surge, but Pfizer-BioNTech bivalent booster retains effectiveness Post author: Post published:October 30, 2023 Post category:uncategorized The efficacy of the bivalent Pfizer-BioNTech COVID-19 messenger ribonucleic acid (mRNA) vaccine BNT162b2 BA.4/5. You Might Also Like Could a handful of nuts a day prevent cognitive decline? February 2, 2025 Study: General service in the US military may lower the risk of depression May 29, 2025 A Discussion with Hologic’s Tim Simpson on the Future of Cervical Cancer Screening August 1, 2024